Abstract
Many efforts have been made in the worldwide quest for a prophylactic HIV vaccine to end the AIDS pandemic, but none has yet succeeded. The lessons learned have repeatedly informed us that the traditional or conventional approaches directly using the pathogens or subunits will not be sufficient for an effective HIV/AIDS vaccine. Recent advances in structure-based technology have shown some promise in the quest for a better immunogen in HIV vaccine development. According to the basic binding structural relationship of an antigen and an antibody, structurebased antigen design could bring some hope for the development of an effective vaccine against HIV.
Keywords: Antibody epitope, envelope trimer, germline B-cells, HIV-1, immunogen design, structure-based design, vaccine development.
Current HIV Research
Title:Recent Advances on the Use of Structural Biology for the Design of Novel Envelope Immunogens of HIV-1
Volume: 11 Issue: 6
Author(s): Shi-Hua Xiang
Affiliation:
Keywords: Antibody epitope, envelope trimer, germline B-cells, HIV-1, immunogen design, structure-based design, vaccine development.
Abstract: Many efforts have been made in the worldwide quest for a prophylactic HIV vaccine to end the AIDS pandemic, but none has yet succeeded. The lessons learned have repeatedly informed us that the traditional or conventional approaches directly using the pathogens or subunits will not be sufficient for an effective HIV/AIDS vaccine. Recent advances in structure-based technology have shown some promise in the quest for a better immunogen in HIV vaccine development. According to the basic binding structural relationship of an antigen and an antibody, structurebased antigen design could bring some hope for the development of an effective vaccine against HIV.
Export Options
About this article
Cite this article as:
Xiang Shi-Hua, Recent Advances on the Use of Structural Biology for the Design of Novel Envelope Immunogens of HIV-1, Current HIV Research 2013; 11 (6) . https://dx.doi.org/10.2174/1570162X113116660053
DOI https://dx.doi.org/10.2174/1570162X113116660053 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
Call for Papers in Thematic Issues
HIV Vaccine Development.
The development of a safe and effective vaccine that impedes HIV-1 transmission and/or limits the severity of infection remains a public health priority. The HIV-1/AIDS pandemic continues to have a disproportionate impact on vulnerable and under-served communities in the USA and globally. In the USA, minority communities that have relatively ...read more
Lymphomas in People Living with HIV (PLWH)
In the era of combined antiretroviral therapy (cART), the incidence of lymphoma among people living with HIV (PLWH) surpassed Kaposi's sarcoma in 2011, becoming the most common AIDS-defining malignancy. The annual incidence rate ranges approximately from 100 to 300 per 100,000 individuals with HIV infection as the population denominator, which ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers